Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Non-cash Items: 2020-2021

  • Avidity Biosciences' Non-cash Items rose 239.03% to $1.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $1.9 million, marking a year-over-year increase of 239.03%. This contributed to the annual value of $59.0 million for FY2021, which is 9.42% down from last year.
  • Latest data reveals that Avidity Biosciences reported Non-cash Items of $1.9 million as of Q4 2021, which was up 239.03% from $556,000 recorded in Q4 2020.
  • Over the past 5 years, Avidity Biosciences' Non-cash Items peaked at $1.9 million during Q4 2021, and registered a low of $556,000 during Q4 2020.
  • Moreover, its 2-year median value for Non-cash Items was $1.2 million (2020), whereas its average is $1.2 million.
  • Data for Avidity Biosciences' Non-cash Items shows a peak YoY surged of 239.03% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Avidity Biosciences' Non-cash Items stood at $556,000 in 2020, then skyrocketed by 239.03% to $1.9 million in 2021.